Toradol amp 30mg/1ml #5

International Name: Ketorolac

Active Ingredient:

 Ketorolac

Clinical-Pharmacological Group:

Non-steroidal anti-inflammatory drug (NSAID) with analgesic properties.

Composition and Form of Release:

Tablets:

 Each tablet contains 10 mg of ketorolac tromethamine (pack of 20).

 Solution for i/m or i/v injection:

Each ampoule (1 ml) contains 30 mg of ketorolac tromethamine (pack of 5).

Indications:

Short-term relief of moderate to severe pain requiring analgesia comparable to that achieved with opioids.
Toradol is not indicated for the treatment of chronic pain syndromes.

Dosage and Administration:

• In adults, the total duration of multiple i/m or i/v Toradol injections should not exceed 5 days, as prolonged use increases the risk of side effects.
  
  

• The duration of i/v infusion in adults should not exceed 24 hours.
  
  

• In children, the total duration of parenteral use should not exceed 2 days.
  
  

• Oral administration in adults should be for no longer than 7 days.
  
  

Solution for Injection:

• Designed for single or multiple intramuscular or intravenous administration in adults.
  
  

• In children, may be given as a single intramuscular dose, with additional i/v injections if necessary (preferably i/v due to injection pain).
  
  

Recommended Dosage:

• Adults (under 65 years):
  
  

• i/m: 10–60 mg single dose depending on pain intensity.
  
  

• i/v: 10–30 mg single dose.
  
  

• Adults over 65 years or with renal impairment:
  
  

• i/m: 10–30 mg single dose.
  
  

• i/v: 10–15 mg single dose.
  
  

Tablets:

• For adults: 10 mg once or every 4–6 hours as needed.
  
  

• Maximum daily dose: 40 mg.
  
  

• Tablets are not recommended for children due to insufficient clinical data.
  
  

Administration Notes:

• The lowest effective dose should always be used.
  
  

• The drug may be combined with low-dose opioids if required.
  
  

• IV administration should last at least 15 seconds.
  
  

• IM injection should be deep and slow.
  
  

• Analgesic effect begins in ~30 minutes, peaks in 1–2 hours, and lasts 4–6 hours.
  
  

• Before use, hypovolemia should be corrected; only use in patients with normal hydration and electrolyte balance.
  
  

Precautions:

• Hypersensitivity reactions (including bronchospasm or anaphylaxis) may occur; appropriate emergency measures must be available.
  
  

• Use in children under 2 years is not recommended due to limited experience.